Spectrum Formulation Private Limited - Due diligence report

A 360° intelligence report on Spectrum Formulation Private Limited: trust score, financial health, credit view, compliance, directors, growt…

2005-05-05 Indore, Madhya Pradesh Active Unlisted Active Compliant
Share
SF Spectrum Formulation Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Spectrum Formulation Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
71/100
Trust Score
Moderate

Spectrum Formulation Private Limited is assessed as Moderate with a Trust Score of 71/100. Spectrum Formulation Private Limited is an active private limited indian non-government company incorporated in 2005, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Spectrum Formulation Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
71/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
78/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
45/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
20/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
75/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 20/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 38%).

Charges position: 3 open (9.42 cr) · 8 satisfied (7.62 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Axis Bank Limited5 48.0 cr
Punjab National Bank3 48.0 cr
Others3 48.0 cr
Compliance Score: 78/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • Delayed payments to MSME suppliers disclosed (443 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 75/100
NameDIN / PANDesignationAppointedTenureDIN status
HARSH AGGARWAL 01234567 Director 01/04/2018 6 yrs Approved
SHUBHAM GUPTA 01234567 Director 01/04/2018 6 yrs Approved
Anurag Aggarwal 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 4 director exits in 3 years - high churn.
Director & KMP remuneration (FY 2025)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Asset base grew 24% - capacity expansion.
Operating for 21+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 0.86 in a year.
3 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 1.67 cr.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence72/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment42/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 9.42 cr already registered.
  • Compliance record supports lending.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
09 Jan 2025
Charge satisfied
Axis Bank Limited
31 Dec 2024
Charge created
Axis Bank Limited - 2.20 cr
15 May 2024
Charge created
Axis Bank Limited - 2.70 cr
04 Oct 2023
Charge satisfied
Others
29 Sep 2023
Director ceased
Aman Aggarwal
Director ceased
HARSH AGGARWAL
Director ceased
SHUBHAM GUPTA
Director ceased
Anurag Aggarwal
05 Jan 2023
Director ceased
SHAMSHAD AHMED
03 Jan 2023
Director appointed
SHUBHAM GUPTA (Director)
12 Nov 2022
Director ceased
MARUF KHAN
11 Nov 2022
Director appointed
HARSH AGGARWAL (Director)
Director appointed
Anurag Aggarwal (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Vinayak Organics Pvt Ltd U72200GJ1992PTC017419 Vaghodia, Gujarat, India
K.S. Surgical Private Limited U33111UP2012PTC052643 Modinagar, Uttar Pradesh, India
Inventys U74210MH2005PTC157304 Mumbai, Maharashtra, India
Apindia Biotech Private Limited U24232MP1998PTC062825 Indore, Madhya Pradesh, India
Odin Healthcare Private Limited U24230HP2005PTC028090 Solan, Himachal Pradesh, India
Sb Lifesciences Private Limited U24304HR2020PTC085143 Panchkula, Haryana, India
Eskag Sanjeevani U24234WB1977PTC030897 Kolkata, West Bengal, India
Amol Pharma U24230RJ1996PTC097657 Jaipur, Rajasthan, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Spectrum Formulation Private Limited before audits and certifications: compliance score 78/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Spectrum Formulation Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 20/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 85/100, margin trends, ownership structure and peer set for Spectrum Formulation Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 71/100, distress signals and MSME payment-delay disclosures - know whether Spectrum Formulation Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Spectrum Formulation Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Spectrum Formulation Private Limited an active company?

Spectrum Formulation Private Limited has MCA status “Active” with a compliance score of 78/100 (Low Risk).

Is Spectrum Formulation Private Limited financially healthy?

Spectrum Formulation Private Limited has a Financial Health Score of 45/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Spectrum Formulation Private Limited?

Its overall Trust Score is 71/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Spectrum Formulation Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Spectrum Formulation Private Limited have loans or charges against its assets?

3 open charge(s) are registered against its assets, and 8 earlier charge(s) stand satisfied.

Is Spectrum Formulation Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 78/100 (Low Risk).

Is it risky to lend to Spectrum Formulation Private Limited?

Its Credit Risk Score is 20/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.